This is a preview of subscription content, log in via an institution to check access.
Reference
Meng Y, et al. Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, and Pentoxifylline for the Treatment of Intermittent Claudication in People With Peripheral Arterial Disease. Angiology : 31 Jan 2013. Available from: URL: http://dx.doi.org/10.1177/0003319712474335
Rights and permissions
About this article
Cite this article
Naftidrofuryl oxalate "first choice" in intermittent claudication. PharmacoEcon Outcomes News 672, 7 (2013). https://doi.org/10.1007/s40274-013-0173-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0173-4